VISIOMED GROUP – Information regarding the total number of voting rights and the number of shares that make up the capital – 01/03/2022 – 6:00 pm.

Paris, January 3, 2022

VISIOMED GROUP (FR0013481835 – ALVMG) publishes information regarding the total number of voting rights and the number of shares that make up its capital, in accordance with the provisions of Article 223-16 of the General Regulations for the Power of Funders.

¹ The total number of exercisable voting rights is calculated on the basis of all theoretical voting rights minus the shares deprived of voting rights.

About the Physiomed group

Founded in 2007, VISIOMED GROUP develops and markets innovative, uses-focused health products and services. Its mission: to make innovation at the service of everyone’s health, starting with everyone’s needs. BewellConnect®, its Connected Health subsidiary, today focuses all of the VISIOMED Group’s expertise in e-health for the general public as well as for players in the world of health through a complete ecosystem of solutions that improve prevention, medical care and follow-up. It has evolved and markets in particular VisioCheck®, 1^time A mobile and connected teleconsultation station weighing less than 300g.

In August 2021, VISIOMED Group acquired Smart Salem (smartsalem.ae), the only digital medical center approved by the Dubai Ministry of Health (DHA) as well as by the General Directorate of Residency and Foreign Affairs (GDRFA) in the UAE.

Headquartered in Paris, the VISIOMED Group is listed on Euronext Growth (ALVMG). More information about visiomed-group.com And www.bewell-connect.com

Contacts

© Visiomed Group SA 2021. The trademarks quoted are the property of their respective authors. Reproduction is prohibited, even in part, without prior permission.